Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
Clinical trial NCT00585312 · TERMINATED
Trial details
- NCT number
- NCT00585312
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2013-10-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.